Neuren Pharmaceuticals Ltd. (NURPF)
8.875
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Neuren Pharmaceuticals Market Cap : 1.123B for May 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Starpharma Holdings Ltd. | 183.21M |
| Percheron Therapeutics Ltd. | 3.806M |
| Mayne Pharma Group Ltd. | 113.74M |
| Acrux Ltd. | 6.875M |
| Invion Ltd. | 3.578M |
Market Cap Related Metrics
| PE Ratio | 59.13 |
| PS Ratio | 27.79 |
| Price to Free Cash Flow | 14.13 |
| Price | 8.875 |
| Earnings Yield | 1.69% |
| Operating PE Ratio | 81.71 |
| Normalized PE Ratio | 54.99 |